معرفی
Ed Schwalbe is an Associate Professor at Northumbria University's Applied Sciences Department, specializing in pediatric oncology and molecular biology of cancer. He holds an external position at Newcastle University since 2013. His research focuses on medulloblastoma molecular subgroups, clinical outcomes, and epigenetic mechanisms. He is a co-investigator on a major project exploring maternal folate's role in childhood leukemia.
Education: PhD in Biological Sciences (2007–2011) from Newcastle University, focusing on medulloblastoma molecular subclassification and disease prognostication.
Research Interests: Schwalbe's work centers on medulloblastoma subtypes, DNA methylation patterns, and their clinical implications. Key areas include molecular subgrouping for treatment stratification, survival prediction, and biomarker discovery. Recent studies emphasize MYC-family amplified tumors and relapse mechanisms.
Articles Overview: His publications highlight advancements in subgroup-specific prognostication, survival outcomes, and therapeutic insights. Recent work includes multicenter cohort analyses and meta-analyses defining high-risk variants in SHH subtypes. Metabolomics and proteomics approaches are increasingly used for non-invasive diagnostics.
Awards: 2014 McElwain Prize for contributions to childhood cancer research.
Grants & Projects: Leading a World Cancer Research Fund project (2023–2027) on maternal folate and leukemia etiology. Collaborates internationally on medulloblastoma subgrouping and clinical trials.
Labs/Teams: Engaged with multidisciplinary teams in neuro-oncology and epigenetics, contributing to centralized diagnostics for rare tumors.